Creutzfeldt-Jakob disease: managing the risk of transmission by blood, plasma, and tissues
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Bethesda, Md.
AABB Press
2006
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XVI, 319 S. Ill., graph. Darst. |
| ISBN: | 1563952246 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV021753216 | ||
| 003 | DE-604 | ||
| 005 | 20070509 | ||
| 007 | t | ||
| 008 | 061004s2006 xxuad|| |||| 00||| eng d | ||
| 010 | |a 2006047625 | ||
| 020 | |a 1563952246 |c perfect bound |9 1-56395-224-6 | ||
| 035 | |a (OCoLC)70218006 | ||
| 035 | |a (DE-599)BVBBV021753216 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-355 | ||
| 050 | 0 | |a RC394.C83 | |
| 082 | 0 | |a 616.8/3 | |
| 084 | |a YG 4503 |0 (DE-625)153499:12909 |2 rvk | ||
| 245 | 1 | 0 | |a Creutzfeldt-Jakob disease |b managing the risk of transmission by blood, plasma, and tissues |c ed.: Marc L. Turner |
| 264 | 1 | |a Bethesda, Md. |b AABB Press |c 2006 | |
| 300 | |a XVI, 319 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Creutzfeldt-Jakob disease | |
| 650 | 4 | |a Brain |x Infections | |
| 650 | 4 | |a Cross infection |x Prevention | |
| 650 | 4 | |a Risk management | |
| 650 | 4 | |a Creutzfeldt-Jakob Syndrome |x prevention & control | |
| 650 | 4 | |a Biological Specimen Banks |x organization & administration | |
| 650 | 4 | |a Creutzfeldt-Jakob Syndrome |x transmission | |
| 650 | 4 | |a Infection Control |x methods | |
| 650 | 4 | |a Risk Factors | |
| 650 | 4 | |a Risk Management | |
| 650 | 0 | 7 | |a Jakob-Creutzfeldt-Syndrom |0 (DE-588)4220958-4 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Jakob-Creutzfeldt-Syndrom |0 (DE-588)4220958-4 |D s |
| 689 | 0 | |C b |5 DE-604 | |
| 700 | 1 | |a Turner, Marc L. |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014966407&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-014966407 | ||
Datensatz im Suchindex
| _version_ | 1804135611560361984 |
|---|---|
| adam_text | Table
Preface
About the Editor
1.
Jonathan D. F. Wadsworth, PhD, DIC, and
John Collinge, CBE, FRS
Aberrant Metabolism of the Prion Protein
Is the Central Feature of Prion Disease
Human Prion Diseases Are Biologically Unique
The Protein-Only Hypothesis of Prion Propagation
Structural Properties and Putative Function of PrPc
Structural Properties of PrPSc
Prion Disease Pathology and Pathogenesis
Cell Death in Prion Disease
The Molecular Basis of Prion Strain Diversity
A Conformational Selection Model of Prion
Transmission Barriers
Future Perspective
References
2.
Transmissible Spongiform Encephalopathies
Moira
TSE Agent Accumulation
Normal and Pathologie PrP in Lymphoid
Role of
Effects of Temporary Ablation of FDCs
Mechanism of FDC Infection
Uptake and Transport of
Spread of Infectivity Between Lymphoid Organs
Spread of Infectivity to the Nervous System
Implications for Iatrogenic Spread and
Prophylactic Treatments
Conclusion
References
CREUTZFELDT-JAKOB
3.
Prion Diseases
James W. Ironside, BMScOums), MBChB, FRCPath,
FRCPiEd), FMedSd
Neuropathology of Prion Diseases
PrPTSE Biochemistry
Sporadic CJD
Familial Prion Diseases
Iatrogenic CJD
Kuru
Variant CJD
Conclusion
Acknowledgments
References
4.
Encephalopathies
Paul Brown, MD
Issues of Interpretation
Animal Studies
Observations in Humans
Conclusion
References
5.
Creutzfeldt-Jakob Disease
Philip Minor,
Types of Tests
PrPTSH
Immunoblotting
Immunocapillary Electrophoresis
Conformation-Dependent Irmmmoassay
PrP^-Specific Antibodies
PrPTSE-Binding Ligands
Amplification Methods
Other Methods
Cell-Based Bioassays
Evaluation of Approaches
Summary and Conclusions
References
TABLE
6.
to Reduce vCJD Transmission Risk
Rebecca Cardigan, BSc, PhD, and
MD, FRCP, FRCPath
Risk Assessments of Distribution of Prion
Infectivity in Blood Components
Strategies Adopted to Reduce vCJD Risk Through
Component Procurement and Processing
Universal LR of Blood Components
Minimizing Plasma Exposure
Through Red Cell Transfusion
Prion Reduction Technology
Reducing Exposure to Multiple Donors and to
Donor Plasma in the Preparation of Platelets
Strategies for Frozen Plasma Components
Acknowledgments
References
7.
Peter R. Foster, BScr MSc, PhD, CS, CSci, CEng, FIChetnE
Experimental Systems
Plasma Fractionation
Plasma Products
Remaining Issues
Conclusion
References
8.
George
Turner, MB, ChB, PhD, FRCP, FRCPath
Distribution of Infectivity in Cells, Tissues, and
Organs
Iatrogenic Transmission of CJD
Risk Assessment
Risk-Reduction Measures
Conclusions
References
CREUTZFELDT-JAKOB
9 .
Disease and Blood Transfusion: A Perspective
from the United Kingdom
Peter Bennett, BSc, MSc, PhD, and Stephen
MSc, MSc, MBA
Background
Assessing and Reducing Risks to the Population
Assessments for Individual Incidents
New Measures and Outstanding Issues
References
10.
Marc L. Turner, MB, ChB, PhD, FRCP, FRCPath
The Nature of the Infectious Agent
The Prevalence and Distribution of Subclinical
Disease in the Donor Population
Distribution of Infectivity in the Peripheral Tissues
in Prion Diseases
Transmissibility of Prion Diseases by
Blood and Tissues
Risk Management Approaches
Conclusions
References
Index
|
| adam_txt |
Table
Preface
About the Editor
1.
Jonathan D. F. Wadsworth, PhD, DIC, and
John Collinge, CBE, FRS
Aberrant Metabolism of the Prion Protein
Is the Central Feature of Prion Disease
Human Prion Diseases Are Biologically Unique
The Protein-Only Hypothesis of Prion Propagation
Structural Properties and Putative Function of PrPc
Structural Properties of PrPSc
Prion Disease Pathology and Pathogenesis
Cell Death in Prion Disease
The Molecular Basis of Prion Strain Diversity
A Conformational Selection Model of Prion
Transmission Barriers
Future Perspective
References
2.
Transmissible Spongiform Encephalopathies
Moira
TSE Agent Accumulation
Normal and Pathologie PrP in Lymphoid
Role of
Effects of Temporary Ablation of FDCs
Mechanism of FDC Infection
Uptake and Transport of
Spread of Infectivity Between Lymphoid Organs
Spread of Infectivity to the Nervous System
Implications for Iatrogenic Spread and
Prophylactic Treatments
Conclusion
References
CREUTZFELDT-JAKOB
3.
Prion Diseases
James W. Ironside, BMScOums), MBChB, FRCPath,
FRCPiEd), FMedSd
Neuropathology of Prion Diseases
PrPTSE Biochemistry
Sporadic CJD
Familial Prion Diseases
Iatrogenic CJD
Kuru
Variant CJD
Conclusion
Acknowledgments
References
4.
Encephalopathies
Paul Brown, MD
Issues of Interpretation
Animal Studies
Observations in Humans
Conclusion
References
5.
Creutzfeldt-Jakob Disease
Philip Minor,
Types of Tests
PrPTSH
Immunoblotting
Immunocapillary Electrophoresis
Conformation-Dependent Irmmmoassay
PrP^-Specific Antibodies
PrPTSE-Binding Ligands
Amplification Methods
Other Methods
Cell-Based Bioassays
Evaluation of Approaches
Summary and Conclusions
References
TABLE
6.
to Reduce vCJD Transmission Risk
Rebecca Cardigan, BSc, PhD, and
MD, FRCP, FRCPath
Risk Assessments of Distribution of Prion
Infectivity in Blood Components
Strategies Adopted to Reduce vCJD Risk Through
Component Procurement and Processing
Universal LR of Blood Components
Minimizing Plasma Exposure
Through Red Cell Transfusion
Prion Reduction Technology
Reducing Exposure to Multiple Donors and to
Donor Plasma in the Preparation of Platelets
Strategies for Frozen Plasma Components
Acknowledgments
References
7.
Peter R. Foster, BScr MSc, PhD, CS, CSci, CEng, FIChetnE
Experimental Systems
Plasma Fractionation
Plasma Products
Remaining Issues
Conclusion
References
8.
George
Turner, MB, ChB, PhD, FRCP, FRCPath
Distribution of Infectivity in Cells, Tissues, and
Organs
Iatrogenic Transmission of CJD
Risk Assessment
Risk-Reduction Measures
Conclusions
References
CREUTZFELDT-JAKOB
9 .
Disease and Blood Transfusion: A Perspective
from the United Kingdom
Peter Bennett, BSc, MSc, PhD, and Stephen
MSc, MSc, MBA
Background
Assessing and Reducing Risks to the Population
Assessments for Individual Incidents
New Measures and Outstanding Issues
References
10.
Marc L. Turner, MB, ChB, PhD, FRCP, FRCPath
The Nature of the Infectious Agent
The Prevalence and Distribution of Subclinical
Disease in the Donor Population
Distribution of Infectivity in the Peripheral Tissues
in Prion Diseases
Transmissibility of Prion Diseases by
Blood and Tissues
Risk Management Approaches
Conclusions
References
Index |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| building | Verbundindex |
| bvnumber | BV021753216 |
| callnumber-first | R - Medicine |
| callnumber-label | RC394 |
| callnumber-raw | RC394.C83 |
| callnumber-search | RC394.C83 |
| callnumber-sort | RC 3394 C83 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | YG 4503 |
| ctrlnum | (OCoLC)70218006 (DE-599)BVBBV021753216 |
| dewey-full | 616.8/3 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.8/3 |
| dewey-search | 616.8/3 |
| dewey-sort | 3616.8 13 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01811nam a2200481zc 4500</leader><controlfield tag="001">BV021753216</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20070509 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">061004s2006 xxuad|| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2006047625</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1563952246</subfield><subfield code="c">perfect bound</subfield><subfield code="9">1-56395-224-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)70218006</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV021753216</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC394.C83</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.8/3</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YG 4503</subfield><subfield code="0">(DE-625)153499:12909</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Creutzfeldt-Jakob disease</subfield><subfield code="b">managing the risk of transmission by blood, plasma, and tissues</subfield><subfield code="c">ed.: Marc L. Turner</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Bethesda, Md.</subfield><subfield code="b">AABB Press</subfield><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVI, 319 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Creutzfeldt-Jakob disease</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Brain</subfield><subfield code="x">Infections</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cross infection</subfield><subfield code="x">Prevention</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Risk management</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Creutzfeldt-Jakob Syndrome</subfield><subfield code="x">prevention & control</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological Specimen Banks</subfield><subfield code="x">organization & administration</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Creutzfeldt-Jakob Syndrome</subfield><subfield code="x">transmission</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infection Control</subfield><subfield code="x">methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Risk Factors</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Risk Management</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Jakob-Creutzfeldt-Syndrom</subfield><subfield code="0">(DE-588)4220958-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Jakob-Creutzfeldt-Syndrom</subfield><subfield code="0">(DE-588)4220958-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Turner, Marc L.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014966407&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-014966407</subfield></datafield></record></collection> |
| id | DE-604.BV021753216 |
| illustrated | Illustrated |
| index_date | 2024-07-02T15:32:45Z |
| indexdate | 2024-07-09T20:43:16Z |
| institution | BVB |
| isbn | 1563952246 |
| language | English |
| lccn | 2006047625 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-014966407 |
| oclc_num | 70218006 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | XVI, 319 S. Ill., graph. Darst. |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| publisher | AABB Press |
| record_format | marc |
| spelling | Creutzfeldt-Jakob disease managing the risk of transmission by blood, plasma, and tissues ed.: Marc L. Turner Bethesda, Md. AABB Press 2006 XVI, 319 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Creutzfeldt-Jakob disease Brain Infections Cross infection Prevention Risk management Creutzfeldt-Jakob Syndrome prevention & control Biological Specimen Banks organization & administration Creutzfeldt-Jakob Syndrome transmission Infection Control methods Risk Factors Risk Management Jakob-Creutzfeldt-Syndrom (DE-588)4220958-4 gnd rswk-swf Jakob-Creutzfeldt-Syndrom (DE-588)4220958-4 s b DE-604 Turner, Marc L. Sonstige oth Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014966407&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Creutzfeldt-Jakob disease managing the risk of transmission by blood, plasma, and tissues Creutzfeldt-Jakob disease Brain Infections Cross infection Prevention Risk management Creutzfeldt-Jakob Syndrome prevention & control Biological Specimen Banks organization & administration Creutzfeldt-Jakob Syndrome transmission Infection Control methods Risk Factors Risk Management Jakob-Creutzfeldt-Syndrom (DE-588)4220958-4 gnd |
| subject_GND | (DE-588)4220958-4 |
| title | Creutzfeldt-Jakob disease managing the risk of transmission by blood, plasma, and tissues |
| title_auth | Creutzfeldt-Jakob disease managing the risk of transmission by blood, plasma, and tissues |
| title_exact_search | Creutzfeldt-Jakob disease managing the risk of transmission by blood, plasma, and tissues |
| title_exact_search_txtP | Creutzfeldt-Jakob disease managing the risk of transmission by blood, plasma, and tissues |
| title_full | Creutzfeldt-Jakob disease managing the risk of transmission by blood, plasma, and tissues ed.: Marc L. Turner |
| title_fullStr | Creutzfeldt-Jakob disease managing the risk of transmission by blood, plasma, and tissues ed.: Marc L. Turner |
| title_full_unstemmed | Creutzfeldt-Jakob disease managing the risk of transmission by blood, plasma, and tissues ed.: Marc L. Turner |
| title_short | Creutzfeldt-Jakob disease |
| title_sort | creutzfeldt jakob disease managing the risk of transmission by blood plasma and tissues |
| title_sub | managing the risk of transmission by blood, plasma, and tissues |
| topic | Creutzfeldt-Jakob disease Brain Infections Cross infection Prevention Risk management Creutzfeldt-Jakob Syndrome prevention & control Biological Specimen Banks organization & administration Creutzfeldt-Jakob Syndrome transmission Infection Control methods Risk Factors Risk Management Jakob-Creutzfeldt-Syndrom (DE-588)4220958-4 gnd |
| topic_facet | Creutzfeldt-Jakob disease Brain Infections Cross infection Prevention Risk management Creutzfeldt-Jakob Syndrome prevention & control Biological Specimen Banks organization & administration Creutzfeldt-Jakob Syndrome transmission Infection Control methods Risk Factors Risk Management Jakob-Creutzfeldt-Syndrom |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014966407&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT turnermarcl creutzfeldtjakobdiseasemanagingtheriskoftransmissionbybloodplasmaandtissues |